
Loading, please wait...

Loading, please wait...

Smoking cessation presents unique challenges for marginalized groups who often lack access to tailored support. Consequently, a recent pilot study evaluated the EQQUAL program as a specialized SGM smoking cessation intervention. Specifically, this avatar-led digital health program utilizes Acceptance and Commitment Therapy (ACT) to help sexual and gender minority (SGM) young adults quit smoking.
Researchers recruited 124 participants aged 18 to 30 for this randomized controlled pilot trial. The team divided the cohort into two groups to compare EQQUAL with the standard Smokefree.gov program. Both interventions provided users with a web application and integrated text messaging services. After three months, the team assessed smoking abstinence through biochemical verification.
Results indicated that EQQUAL users experienced significantly higher rates of biochemically-verified abstinence. Specifically, 11.1% of the EQQUAL arm remained abstinent compared to only 4.9% in the control group. Moreover, participants reported higher overall satisfaction scores and usability ratings with the tailored digital interface. However, the study found that users only completed an average of 1.4 out of 6 digital sessions.
Furthermore, the theory-based change processes did not show robust differences between the two study arms. This suggests that while the tailored content improves immediate abstinence, the mechanism of change requires further investigation. Therefore, clinicians suggest that increasing user engagement might further improve these promising cessation outcomes. This specialized SGM smoking cessation intervention represents a vital step toward reducing health disparities in tobacco use.
Culturally-tailored digital tools offer a scalable solution for high-risk populations. Clinicians should consider such tools to support diverse patient populations effectively, especially those who may avoid traditional healthcare settings due to stigma. While initial results are positive, practitioners should emphasize the importance of completing all digital sessions to maximize the program's benefits.
The EQQUAL program is specifically tailored for sexual and gender minority young adults. It uses an avatar-led interface and Acceptance and Commitment Therapy (ACT) to address the unique psychosocial stressors and barriers this population faces when quitting smoking.
In the pilot trial, the EQQUAL group achieved a biochemically-verified abstinence rate of 11.1%. In contrast, the control group using the Smokefree.gov program achieved a rate of only 4.9%.
Despite higher satisfaction, user engagement remained low, with participants completing an average of only 1.4 out of 6 sessions. Researchers believe that increasing this engagement is key to further improving cessation outcomes.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized pilot trial evaluates EQQUAL, a digital health tool for SGM young adult smoking cessation, showing promising results over standard programs....
4 months ago

A metataxonomic study reveals distinct gut bacteriome biomarkers in type 2 diabetes, obesity, and cardiovascular complications, identifying specific bacterial shifts that pave the way for precision metabolic medicine.
Today

Researchers have engineered HER2-targeted AIE nanotheranostics to overcome SHR-A1811 resistance in breast cancer. By inducing immunogenic pyroptosis and reprogramming tumor-associated macrophages, this multimodal nanoplatform achieves near-complete tumor regression in refractory preclinical models.
Today

A global dose-response meta-analysis of 8.8 million adults reveals that consuming an extra 100 grams of processed food daily raises cardiovascular event risk by 14%. Explore how industrial additives, systemic inflammation, and metabolic disruption heighten long-term multimorbidity and cardiometabolic risks.
Today

A psychometric validation study confirms that the Turkish Copenhagen Hip and Groin Outcome Score (HAGOS-T) offers excellent reliability, construct validity, and interpretability for patients with hip osteoarthritis, providing clinicians with a robust tool for functional assessment.
Today

A landmark dose-response meta-analysis of 8.8 million adults reveals that high ultra-processed food intake significantly elevates risks for cardiovascular disease, cancer, diabetes, depression, and all-cause mortality, highlighting urgent needs for clinical lifestyle interventions.
Today